Quantcast USPTO Rejects Pending Claims On Nebivolol Patent As Unpatentable - Congoo
 
 
Log In
USPTO rejects pending claims on nebivolol patent as unpatentable
Have an interest in this Story?
Sign Up for Real-Time email updates
PharmaBiz  | September 06, 2008

Forest Laboratories, Inc announced that an Office Action in the Reexamination of U S Patent No. 6,545,040 ('the '040 patent') was received from the U S Patent and Trademark Office ('USPTO') by Janssen Pharmaceutica N V, the patent holder of the '040 patent. The '040 patent covers nebivolol, the acti...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Gordon Kauer Gordon Kauer
Sales Rep/News/On Air
Broadcasting Industry
Rama Sethu Ranga Nathan Rama Sethu Ranga Nathan
Consultant Sound/Recording Engineer
Music Industry

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2008 Congoo.com. All Rights Reserved.